Nurix Therapeutics, a clinical stage biopharmaceutical company, is expanding its DAC research team with a hands-on in vitro pharmacology scientist. You will help build the screening and characterization capability for Degrader Antibody Conjugates (DACs) and define the in vitro assay cascade from primary screening through mechanistic pharmacology.
This lab-based role requires designing and running cellular assays to characterize DAC activity, collaborating across discovery biology, conjugation
#J-18808-LjbffrDAC In Vitro Pharmacology Scientist — Screening & Degradation in brisbane at Unknown Company
This position is listed as full time and onsite.